Hongmei Jiao

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Respiratory Syndrome Coronavirus

Oxidative Stress

Top Venues

Infection and drug resistance

Journal of clinical pharmacy and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Lina Wang, Xiaolin Zhang, Bo Huang, Yue Hou, Xinmin Liu, Hongmei Jiao
Ruxolitinib as an Effective Treatment for Hemophagocytic Lymphohistiocytosis Secondary to SARS-Cov-2 Infection: A Case Report. Infection and drug resistance 16 (2023)
Lina Wang, Xiaolin Zhang, Bo Huang, Yue Hou, Xinmin Liu, Hongmei Jiao
Ruxolitinib as an Effective Treatment for Hemophagocytic Lymphohistiocytosis Secondary to SARS-Cov-2 Infection: A Case Report. Infection and drug resistance 16 (2023)
Jingjing Han, Shuo Xie, Hongmei Jiao
Sodium-glucose cotransporter-2 inhibitor-induced euglycemic diabetic ketoacidosis: A case report. Journal of clinical pharmacy and therapeutics 47 (9) (2022)